SCHEMBL3750109

SCHEMBL3750109

O=C1Cc2ccccc2C(=O)N1CCc1ccc(Cl)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.79
GAA P10253 5/20 0.79
APAF1 O14727 3/20 0.79
MAPT P10636 3/20 0.79
ALDH1A1 P00352 3/20 0.79
HSD17B10 Q99714 2/20 0.79
CASP1 P29466 1/20 0.79
RAB9A P51151 1/20 0.79
BLM P54132 1/20 0.79
CASP7 P55210 1/20 0.79
MEN1 O00255 6/20 0.61
HPGD P15428 1/20 0.61
L3MBTL1 Q9Y468 2/20 0.59
CASP6 P55212 2/20 0.59
POLB P06746 1/20 0.59
CASP3 P42574 1/20 0.55
SENP8 Q96LD8 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SENP6 Q9GZR1 1/20 0.55
ACHE P22303 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2591104 0.88 KMT2A (1.00) KMT2AGAAAPAF1MAPTALDH1A1
SCHEMBL18669052 0.82 CASP3 (0.65) KMT2AGAAMAPTALDH1A1RAB9A
SCHEMBL10159118 0.80 MAPT (0.81) KMT2AGAAAPAF1MAPTALDH1A1
SCHEMBL10159071 0.79 MAPT (0.69) KMT2AGAAAPAF1MAPTALDH1A1
SCHEMBL5240140 0.77 DRD3 (0.58) KMT2AGAAAPAF1MAPTALDH1A1
SCHEMBL2593843 0.77 ALDH1A1 (0.64) KMT2AGAAAPAF1MAPTALDH1A1
SCHEMBL3745584 0.77 CASP3 (0.77) GAAMAPTALDH1A1RAB9ACASP3
SCHEMBL20124834 0.76 KMT2A (0.68) KMT2AGAAAPAF1MAPTALDH1A1
SCHEMBL11280189 0.76 KMT2A (0.68) KMT2AGAAAPAF1MAPTALDH1A1
SCHEMBL9871527 0.76 KMT2A (0.68) KMT2AGAAAPAF1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298392-A1 Isoindoline Derivatives For The Treatment Of Arrhythmias ASTRAZENECA AB (SE) 2010-11-25 US disclosed
EP-2049484-A1 ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIAS AstraZeneca AB (SE) 2009-04-22 EP disclosed
WO-2008008022-A1 ISOINDOLINE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIAS ASTRAZENECA AB (SE) 2008-01-17 WO disclosed
US-20080015237-A1 NEW COMPOUNDS I/418 ASTRAZENECA AB (SE) 2008-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015237-A1 NEW COMPOUNDS I/418 KCNH1, KCNH2, KCNH3 KMT2A 3483/4885GAA 3997/4885APAF1 2348/4885
US-20100298392-A1 Isoindoline Derivatives For The Treatment Of Arrhythmias KCNH1, KCNH2, KCNQ2 KMT2A 3979/4885GAA 4674/4885APAF1 2314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.